Zymeworks Inc. (ZYME)
ZYME price $28.11 +1.21 +4.48%
- Ticker
- ZYME
- Price
- $28.11
- Change
- +1.21 +4.48%
- Market cap
- $2.02B
- P/E
- -13.32
- Forward P/E
- 27.22
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 45
Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline features two primary experimental treatments: zanidatamab, a cutting-edge bispecific antibody currently undergoing Phase 1 and Phase 2 studies for various malignancies such as those affecting the biliary tract…